Pilot study of humanized glypican-3-targeted zirconium-89 immuno-positron emission tomography for hepatocellular carcinoma

EJNMMI Res. 2024 Aug 22;14(1):74. doi: 10.1186/s13550-024-01134-1.
No abstract available